SGCG and rheumatoid arthritis: Although this study comprehensively explored the effects of abnormal type I and II IFN signaling pathways in RA PBMC immune cell subtypes, only one RA scRNA sample was used in our study, and the clinical characteristics of the RA patient were unknown.